Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer
Autor: | Young‐Won Cho, Dong‐Wook Min, Hwang‐Phill Kim, Yohan An, Sheehyun Kim, Jeonghwan Youk, Jaeyoung Chun, Jong Pil Im, Sang‐Hyun Song, Young Seok Ju, Sae‐Won Han, Kyu Joo Park, Tae‐You Kim |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Molecular Oncology, Vol 16, Iss 12, Pp 2396-2412 (2022) |
Druh dokumentu: | article |
ISSN: | 1878-0261 1574-7891 |
DOI: | 10.1002/1878-0261.13144 |
Popis: | Patient‐derived organoids are being considered as models that can help guide personalized therapy through in vitro anticancer drug response evaluation. However, attempts to quantify in vitro drug responses in organoids and compare them with responses in matched patients remain inadequate. In this study, we investigated whether drug responses of organoids correlate with clinical responses of matched patients and disease progression of patients. Organoids were established from 54 patients with colorectal cancer who (except for one patient) did not receive any form of therapy before, and tumor organoids were assessed through whole‐exome sequencing. For comparisons of in vitro drug responses in matched patients, we developed an ‘organoid score’ based on the variable anticancer treatment responses observed in organoids. Very interestingly, a higher organoid score was significantly correlated with a lower tumor regression rate after the standard‐of‐care treatment in matched patients. Additionally, we confirmed that patients with a higher organoid score (≥ 2.5) had poorer progression‐free survival compared with those with a lower organoid score ( |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |